Scientists have made steps towards understanding the genetic changes found in various types of tumour. William R. Sellers and colleagues report a significant advance in this area in the 07 July 2005 issue of Nature (Vol. 436, No. 7047, pp. 116-121). The researchers used DNA chips that allow ultra-high resolution genetic analyses. This helped them to find a distinct amplification of the gene encoding MITF (microphthalmia-associated transcription factor) in melanoma cells.
They also found that increased amounts of this master regulatory protein could explain why these cancerous cells show such high resistance to conventional melanoma chemotherapy. The authors believe that targeting MITF could offer new options to treat cancer,
and other experts agree.
"Over-reliance on lineage-defining factors such as MITF could be a weak link in an otherwise unbreakable chain, providing an opportunity well worth exploiting therapeutically," writes Glenn Merlino in an accompanying News and Views article.
William R Sellers Dana Farber Cancer Institute, Boston, MA, USA)
Glenn Merlino (National Cancer Institute, National Institutes of Health, Bethesda, MD, USA)
(C) Nature press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking